Is Ginkgo’s synthetic biology story worth $15 billion?

The Boston genetic engineering company Ginkgo Bioworks and its CEO, Jason Kelly, have been spectacularly successful selling a story: that synthetic biology will transform the manufacture of physical products. What computers did...

Read More